Evidence of association of serotonin transporter gene polymorphisms with schizophrenia in a South Indian population

Serotonin (5-hydroxytryptamine (5-HT)) transporter (SLC6A4) is known to influence mood, emotion, cognition and efficacy of antidepressants, particularly that of selective serotonin reuptake inhibitors. Atypical antipsychotics exert their effects partially through serotinergic systems, and hence, variation in 5-HT uptake may affect antipsychotic action mediated through the serotinergic system. Therefore, investigating the role of SLC6A4 as a risk factor for developing schizophrenia and treatment response had been a point of concern for many investigators, but with variable outcome. In this study, we examined the genetic roles of five polymorphisms of SLC6A4, including those of the widely studied 44 base pair variable number of tandem repeat (VNTR) in the promoter region of SLC6A4 (the serotonin transporter gene-linked polymorphic region: 5HTTLPR) and a VNTR polymorphism (STin2) in the second intron, in schizophrenia and its influence on the severity of symptoms in a South Indian population from Kerala, comprising 586 individuals. We detected significant allelic and genotypic associations with rs2066713 (both allelic and genotypic P-value <0.001), 5HTTLPR (allelic P-value=0.008 and genotypic P-value=0.03) and STin2 polymorphisms (allelic P-value=0.001 and genotypic P-value=0.002). A haplotype linking these three risk alleles, 5HTTLPR/S-rs2066713/C-STin2/12-repeat (P-value=0.0059), was also significantly associated with disease in our population. Patients with STin2 12-repeat homozygotes showed a greater severity of blunted effect symptom. These results suggest a strong role of SLC6A4 in schizophrenia, possibly with a specific behavioral endophenotype in a South Indian population.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  N. Newberry,et al.  Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat. , 1990, European journal of pharmacology.

[3]  B. Roth,et al.  Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. , 1992, The Journal of pharmacology and experimental therapeutics.

[4]  R. Blakely,et al.  Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. C. Hartzell,et al.  Molecular physiology of norepinephrine and serotonin transporters. , 1994, The Journal of experimental biology.

[6]  G. Uhl,et al.  Neurotransmitter transporters: three important gene families for neuronal function. , 1994, The Journal of experimental biology.

[7]  H. Meltzer,et al.  An overview of the mechanism of action of clozapine. , 1994, The Journal of clinical psychiatry.

[8]  G. Goodwin,et al.  Polymorphism in serotonin transporter gene associated with susceptibility to major depression , 1996, The Lancet.

[9]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[10]  R. Murray,et al.  The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. , 1996, Neuroreport.

[11]  P Riederer,et al.  Allelic Variation of Human Serotonin Transporter Gene Expression , 1996, Journal of neurochemistry.

[12]  Klaus-Peter Lesch,et al.  Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? , 1998, Biological Psychiatry.

[13]  M. Quick,et al.  Neurotransmitter Transporters: Regulators of Function and Functional Regulation , 1998, The Journal of Membrane Biology.

[14]  D. Williams,et al.  The serotonin transporter: a primary target for antidepressant drugs , 1998, Journal of psychopharmacology.

[15]  C. Fiskerstrand,et al.  An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells , 1999, FEBS letters.

[16]  J. Quinn,et al.  A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Clair,et al.  Tentative association of the serotonin transporter with schizophrenia and unipolar depression but not with bipolar disorder in Han Chinese. , 1999, Pharmacogenetics.

[18]  K K Kidd,et al.  Population studies of polymorphisms of the serotonin transporter protein gene. , 1999, American journal of medical genetics.

[19]  B Müller-Oerlinghausen,et al.  Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia , 2001, Molecular Psychiatry.

[20]  M. Fleisher,et al.  Molecular Genetics and the Human Personality , 2002 .

[21]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[22]  R. Gainetdinov,et al.  Plasma membrane monoamine transporters: structure, regulation and function , 2003, Nature Reviews Neuroscience.

[23]  F. Dudbridge.  Pedigree disequilibrium tests for multilocus haplotypes , 2003, Genetic epidemiology.

[24]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..

[25]  V. Bubb,et al.  The serotonin transporter intronic VNTR enhancer correlated with a predisposition to affective disorders has distinct regulatory elements within the domain based on the primary DNA sequence of the repeat unit , 2003, The European journal of neuroscience.

[26]  Margot Albus,et al.  Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression , 2004, Biological Psychiatry.

[27]  G. Oliveira,et al.  Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism , 2004, Molecular Psychiatry.

[28]  M. Banerjee,et al.  HLA-B and HLA-C alleles and haplotypes in the Dravidian tribal populations of southern India. , 2004, Tissue antigens.

[29]  D. Linszen,et al.  Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E) , 1995, Psychopharmacology.

[30]  P. Riederer,et al.  Organization of the human serotonin transporter gene , 2005, Journal of Neural Transmission / General Section JNT.

[31]  P. Sklar,et al.  Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia , 2005, Molecular Psychiatry.

[32]  Annemarie Poustka,et al.  The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: Alternative biallelic variation in rhesus monkeys , 2005, Journal of Neural Transmission.

[33]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[34]  Ghazal Zaboli,et al.  Haplotype analysis confirms association of the serotonin transporter (5‐HTT) gene with schizophrenia but not with major depression , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[35]  H. Corrêa,et al.  Is the 5‐HTTLPR polymorphism associated with bipolar disorder or with suicidal behavior of bipolar disorder patients? , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[36]  John P A Ioannidis,et al.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database , 2008, Nature Genetics.

[37]  N. Freimer,et al.  5‐HTTLPR genotype and anxiety‐related personality traits: A meta‐analysis and new data , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.